AzTrials
AzTrials

Dietary ModificationNCT02416284

Compliance to the Norwegian Food-Based Dietary Guidelines in Young Females

A study testing NFBDG in people with Dietary Modification, run by University of Oslo at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Norwegian Directorate of Health recently published the Norwegian food-based dietary guidelines (NFBDG) in 2011. The target for the NFBDG is the general population, and the main aims of these guidelines are to promote public health and prevent chronic degenerative diseases. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Dietary Modification
What is being tested?
NFBDG
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteNorway
Study dates
Sep 2012to Nov 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • female

Who cannot join

  • serious chronic disease requiring medication
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • University of Oslo

    Oslo, 0316

Other trials in Norway

About this study

The Norwegian Directorate of Health recently published the Norwegian food-based dietary guidelines (NFBDG) in 2011. The target for the NFBDG is the general population, and the main aims of these guidelines are to promote public health and prevent chronic degenerative diseases. Reaching the healthy population is crucial as only small proportion of the general population comply to the current public dietary advice in Norway. Thus, the objective of this study is to investigate whether a multi-faceted dietary intervention could increase compliance to the NFBDG and affect biomarkers of chronic degenerative diseases in a healthy population.

Read the detailed description

The study was conducted as part of a master level course in Clinical Nutrition at the University of Oslo. Thus, the main objective of the study was to teach the master students about planning, conducting and analysing data from a clinical trial. The students themselves are subjects of the study, however the participation in the study was voluntary and did in no way affect the approval of the course.

Since the primary objective of the study was teaching, the study was confirmed by the "Regional Committees for Medical and Health Research Ethics" (REC) to be exempt from REC approval.

Being tested
NFBDG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NFBDGOther

    Intervention consists of:

    Lecture presenting the NFBDG, Printed booklet containing the NFBDG, Suggested meal plan for a week, Recipes, Access to a restricted website with further information on the NFBDG, A Facebook-group where "Vegetable of the day" was presented with a suggested recipe, text-messages with encouragement to follow the guidelines, follow-up phone-calls, common exercise sessions, Free common meals (1 breakfast, 2 lunches, 1 dinner), Free foods (low-fat dairy products, a juice containing grapes, blueberries, chokeberries, and cherries and fruits)

Study groups in NCT02416284
Study groupRoleWhat they receive
NFBDGExperimentalMulti-faceted, 2 week intervention to increase compliance to the NFBDG.
Receives: Other: NFBDG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Biomarker of the intake of fruits and vegetables (caroteniods in plasma (uM)

    Measured: 2 weeks

  2. Biomarker of intake of fatty fish and low fat dairy products (fatty acids in red blood cells (fatty acid in % of FAME)

    fatty acids in red blood cells (fatty acid in % of FAME)

    Measured: 2 weeks

  3. Biomarker of the intake of fruits and vegetables (total antioxidant status in plasma (RU)

    Measured: 2 weeks

Secondary outcomes (5)
  1. Lipids in plasma (HDL, LDL, total cholesterol)

    HDL, LDL, total cholesterol

    Measured: 2 weeks

  2. Blood glucose

    Measured: 2 weeks

  3. Blood pressure

    Blood pressure (mmHg)

    Measured: 2 weeks

  4. Weight (body weight in kg)

    body weight in kg

    Measured: 2 weeks

  5. Body composition (bioelectrocal impedance analysis (BIA)

    bioelectrocal impedance analysis (BIA)

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2015 (estimated)
  2. Study startSep 2012
  3. Primary completionNov 2012
  4. Study completionNov 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02416284
Sponsor's protocol ID
ERN4120_2012
Status last verified
Apr 2015
First submitted
3 Apr 2015
Last updated
15 Apr 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing NFBDG in people with Dietary Modification, run by University of Oslo at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Biomarker of the intake of fruits and vegetables (caroteniods in plasma (uM) (time frame: 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in